Browsing publications by Professor Steve Wedge

Newcastle AuthorsTitleYearFull text
Dr Mathew Martin
Elisa Meschini
Lan Wang
Dr Regina Mora Vidal
Tristan Reuillon
et al.
Identification and characterization of an irreversible inhibitor of CDK22014
Professor Steve Wedge
Mechanisms that influence tumour response to VEGF-pathway inhibitors2014
Annalisa Bertoli
Santosh Adhikari
Dr Suzannah Harnor
Dr Yan Zhao
Professor John Lunec
et al.
Validation studies with small-molecule modulators of the MDM2/MDMX-p53 binding interaction2014
Sarah Jane Ross
Dr Fadhel Shaheen
Dr Luke Gaughan
Professor Craig Robson
Professor Steve Wedge
et al.
AZD3514: A Small Molecule That Modulates Androgen Receptor Signaling and Function In Vitro and In Vivo2013
Professor Steve Wedge
Tumour-stromal architecture can define the intrinsic tumour response to VEGF-targeted therapy2013
Professor Steve Wedge
An evaluation of 2-deoxy-2- [18F]fluoro-D-glucose and 3‟-Deoxy-3‟-[18F]-fluorothymidine uptake in human tumor xenograft models2012
Professor Steve Wedge
Expression of stromal genes associated with the angiogenic response are not differentiated between human tumour xenografts with divergent vascular morphologies2012
Professor Steve Wedge
Inhibition of Aurora-B kinase activity confers antitumor efficacy in preclinical mouse models of early and advanced gastrointestinal neoplasia2012
Dr Aileen Taylor
Professor Steve Wedge
The Clinical Development of Molecularly Targeted Agents in Combination With Radiation Therapy: A Pharmaceutical Perspective2012
Professor Steve Wedge
An antibody targeted to VEGFR-2 Ig domains 4-7 inhibits VEGFR-2 activation and VEGFR-2 dependent angiogenesis without affecting ligand binding2011
123456